Blutdruck zu Hause messen und übermitteln: Bringt Telemonitoring weniger Herzinfarkte?

<h4>Aims</h4>It is well established from trials that blood pressure (BP) telemonitoring leads to improved BP control. However, there is little data available on the impact of BP telemonitoring on the incidence of cardiovascular events when it is used as the routine mode of long-term BP monitoring. The objective of this study was to assess the impact of BP telemonitoring on cardiovascular outcomes.<h4>Methods and results</h4>Records were analysed for 454 180 adults with hypertension who had a prescription for a first-line anti-hypertensive drug at any time from 1 March 2019 to 28 February 2021. Follow-up was until 1st March 2022. Women pregnant during that time were excluded. The primary outcome was emergency hospital admission or mortality for Acute Coronary Syndrome (ACS), Stroke, or uncontrolled Heart Failure (HF) within 12 months. Outcomes were compared between people who had used BP telemonitoring for at least 1 year and a group who had never used it, matched for age, sex, ethnicity, social deprivation, number of anti-hypertensive drugs, diabetes, and having a BP assessment in the same year. Ninety percent of the cohort had been diagnosed with hypertension before March 2019. The onset of the COVID-19 pandemic in March 2020 was associated with a rapid increase in the uptake of BP telemonitoring but a reduction in the number of new diagnoses of hypertension. Those who used telemonitoring were significantly younger, less likely to have diabetes, and took less antihypertensiv

High-quality hypertension management is a new concept proposed to improve blood pressure (BP) control in Asia. Out-of-office BP measurements, including ambulatory and home BP monitoring, and wearable BP measurement, are recommended for BP assessment. Long-acting antihypertensive agents at full dose or in combination are priority strategies for achieving 24-h (24-h) BP control, reducing blood pressure variability (BPV) and improving time-in-target range (TTR). High-quality hypertension management across multiple disciplines will be a pragmatic strategy for the reduction in the risk of cardio-cerebrovascular and renal complications and mortality among Asian hypertensive patients.